IASLC Fall Newsletter
Thank You for Joining in the Conversation at #WCLC2018!
IASLC Communications Committee
The recent #WCLC2018 saw the largest attendance, ever, at an IASLC World Conference on Lung Cancer. There were nearly 7,500 delegates from almost 100 countries. A wonderful visual representation of our global community could be seen at our world map, where many stopped by to pin their country. Countless delegates also came by our social media booth to take pictures, write messages and find out more about getting started on social media.
The online conversation took place across a number of social media channels. Many posts were made on Facebook, Instagram, YouTube and LinkedIn. As per previous conferences, Twitter continued to be the most popular channel. There were over 2,600 people tweeting, leading to more than 11,500 tweets and resulting in approximately 36 million impressions. The top ten influencers on Twitter reflected patients, patient advocates and groups, as well as medical oncology, basic science and psycho-oncology.
We would like to thank everyone for taking part in the online conversations and discussions, and for sharing their conference experiences. We encourage members from all areas of the care pathway to help disseminate information across social media when attending our upcoming meetings, particularly the IASLC 20th World Conference on Lung Cancer (#WCLC19) in Barcelona next year.
September, October and November 2018: The IASLC and the Journal of Thoracic Oncology (JTO) are pleased to present the Editor's Choice each month to highlight certain articles of interest. The articles below from the September, October and November 2018 issues of the JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
- Burt et al.
Dr. Martin Reck and colleagues write an excellent accompanying editorial, which puts these findings in perspective.
- Gettinger et al.
Dr. Atagi and colleagues put these findings in perspective, considering currently available therapeutic options.
- Tsao et al.
Dr. Marino provides an insightful accompanying editorial.
- Occhipinti et al.
- Davies et al.
In an accompanying editorial, Dr. Sholl expands on the relevance of these findings.
- Quispel-Janssenet al.
The implications of these results and results from other immune checkpoint studies in mesothelioma are discussed by Dr. Fennell in an accompanying editorial.
- Lin et al
- Su et al.
Current and Future Management of Malignant Mesothelioma : A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer and Mesothelioma Applied Research Foundation
- Tsao et al.
- Roach et al.
- Scott et al.
Members - It's Almost Time to Renew Your Membership for 2019!
All members whose memberships expire December 31, 2018 will begin to receive renewal notices. If you chose a multi-year membership in 2017 or 2018, your membership will continue uninterrupted.
The IASLC has continued the three-year registration options for all categories (except the complimentary Fellow Membership). Our three-year option "locks-in" the current membership rates. Regular members will save $150.00 over three years by selecting the three-year membership option ($600.00). Developing Country Members and Allied Health Professionals can avoid potential future increases and not have to renew each year.
We encourage all members to renew early to ensure there is no interruption of benefits such as JTO delivery and online access. Please review the single-year and multi-year options available to you.
Thinking about joining IASLC as a new member? Watch the video above to understand why the IASLC is an organization like no other!
Thank You for Participating in WCLC 2018!
Thank you to all members who joined us in Toronto, Canada, for the IASLC 19th World Conference on Lung Cancer (WCLC). Over the course of four days, a record-breaking 7,443 lung cancer specialists, researchers, nurses, physicians, survivors, caregivers, advocates and more shared the latest advances in the field, fostered connections and laid the groundwork for future colleaboration.
Check out a few of the conference's highlights in this WCLC 2018 infographic.
Free Membership for Patients/Survivors/Caregivers
The IASLC has a free membership option for patients, survivors and caregivers. All patients/survivors with a diagnosis of lung cancer, mesothelioma or other thoracic cancer, and caregivers providing services and care to loved ones affected by thoracic malignancies qualify for this free, non-voting membership and can review annually.
The membership includes online access to the JTO, member meeting discounts, eligibility to apply for travel awards and eligibility to serve on IASLC committees. Register as Patient/Survivor/Caregiver.
If individuals wish to have a voting membership, they can register here and choose the Allied Health Membership for US$50. Please contact email@example.com with any questions or call +1 720-598-1949.
Welcome New IASLC Members
Review the list of members who joined the IASLC during the past three months.
Global Lung Cancer Coalition & IASLC Partner Project
For this year’s Lung Cancer Awareness Month, the IASLC and Global Lung Cancer Coalition have been partnering on a project to bring to life the progress made in lung cancer treatment and the potential for future advances.
We have interviewed 10 international experts, from advocacy, pathology, surgery, thoracic medicine, interventional pulmonology, specialized nursing, medical oncology and radiation oncology. Each has shared their perspective on the changes they’ve seen in their field, what this has meant for patients and their hopes for future progress.
You can read their thoughts and watch the interviews. Our aim is to celebrate the work and achievements of the lung cancer community and to inspire renewed efforts to advance on all fronts. Please read, watch and share!
Lung Cancer Awareness Month (LCAM) 2018
These cards are geared to be stepping stones for patients, caregiver, and providers on four main topics around lung cancer: screening & early detection, precision medicine, clinical trials and advocacy. To view the online versions and additional resources, please click here. To request the PPC for your clinic or medical office, please reach out to Kristin.Schultz@iaslc.org.
For more information on Lung Cancer Awareness Month 2018, please visit the campaign's official website: lcam.org.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
September 7 - 10 2019Barcelona, Spain
October 10 - 12 2019Chicago, Illinois
October 17 - 19 2019Mexico City, Mexico